Optivir 0.03 is a Product of the Generic Acyclovir (Ophthalmic)

Optivir 0.03 belongs to the generic category of Acyclovir (Ophthalmic). This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Optivir 0.03. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Acyclovir (Ophthalmic) and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Optivir 0.03

Optivir 0.03 may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Optivir 0.03 is provided below to help users gain a clear understanding of this medicine.

What Is Optivir 0.03 Indications and Uses?

Acyclovir is indicated for the treatment of Herpes simplex keratitis.

Pharmacology (Source, Chemical and Physical Composition) Of Optivir 0.03

Acyclovir is an antiviral agent which is highly active in vitro against Herpes simplex (HSV) types I and II and Varicella zoster viruses, but its toxicity to mammalian cells is low. Acyclovir is phosphorylated to the active compound Acyclovir triphosphate after entry into herpes infected cell. The first step in this process requires the presence of the viral-coded thymidine kinase. Acyclovir triphosphate acts as an inhibitor of and substrate for the herpes specified DNA polymerase preventing further viral DNA synthesis without affecting normal cellular processes.

Dosage And Administration of Optivir 0.03

The dosage for all age groups is the same. A 10 mm ribbon of the ointment should be placed inside the lower conjunctival sac five times a day at approximately four hourly intervals. Treatment should continue for at least 3 days after healing

Drug Interactions of Optivir 0.03

No clinically significant interactions have been identified.

Side Effects of Optivir 0.03

Very common: Superficial punctate keratopathy. This did not necessitate an early termination of therapy and healed without apparent sequelae. Common: Transient mild stinging of the eye occurring immediately following application, conjunctivitis. Rare: Blepharitis.

Use During Pregnancy and Lactation

Pregnancy category B. There are no adequate and well-controlled studies of Acyclovir in pregnant women. It is not known whether topically applied Acyclovir is excreted in breast milk.

Precautions And Warnings for Optivir 0.03

The recommended dosage, frequency of applications, and length of treatment should not be exceeded.

Therapeutic Class

Ophthalmic Anti-viral Products

Storage Conditions of It

Store in a cool and dry place. Keep away from light. Keep out of reach of children. Do not touch the tip of the tube since this may contaminate the product. After one month of the opening do not use the medicine of tube.

Optivir 0.03 is a Product of the Generic Acyclovir (Ophthalmic)

Optivir 0.03

Biopharma Limited · Ophthalmic Ointment

Acyclovir (Ophthalmic)